CX3CL1 and tenosynovial giant cell tumor: Moreover, higher expression of the ligand, CX3CL1, was associated with a higher M2 macrophage fraction in LUAD, TGCT (tenosynovial giant cell tumor), and THYM (thymoma) cancer types (Figure 3G).